A Study Using Antihypertensive Therapy for Mild Chronic Hypertension during Pregnancy
Official Title: A Pragmatic Multicenter Trial of Antihypertensive Therapy for Mild Chronic Hypertension during Pregnancy (CHAP)
This study will evaluate the benefits and harms of using medicine in the treatment of mild chronic hypertension (CHTN) in pregnancy.
- Women with either a new or a known diagnosis of chronic hypertension during pregnancy receiving prenatal care at participating centers will be eligible for screening
- Single fetus (twins reduced to singleton or with vanishing twin syndrome prior to 14 weeks qualify)
- Viable pregnancy <23 0/7 weeks of gestation (without preeclampsia / or gestational hypertension).
Anna Bartholomew, RN